Hepatitis C represents a major public health challenge due to its chronic course and major
complications (eg liver tumor and cirrhosis). New treatment strategies (pegylated interferon+ …

OBJECTIVE Depression is a frequent side effect of interferon therapy in patients with chronic
hepatitis C (CHC). The aim of this study was to identify baseline and on-treatment predictors …

Background Antiviral treatment with interferon‐alpha (IFN‐α) is associated with several
acute psychiatric side effects. Little is known about long‐term effects on mental health after …

OBJECTIVE: The prevalence of psychiatric problems and substance abuse is high in the
veteran population with hepatitis C. The purpose of this study was to retrospectively analyze …

BACKGROUND.: Interferon-induced depression ranges from 0 to 50%. Interferon schedule
and a history of psychiatric illnesses are not enough to predict who will develop symptoms …

Low-dose interferon-α is a standard therapy for hepatitis C. Psychotic disorders have been
described as a rare complication of such treatments that resolve with its termination. Here …

Aim Pegylated interferon (P eg IFN) therapies for hepatitis C virus (HCV) infection often
induce a depressive state. This study aimed to identify the risk factors for and clinical …

Abstract Background: Interferon-α (IFN-α) treatment is often associated with psychiatric side
effects and has been found to lower the amount of tryptophan (TRP) available to the brain …

Infectious diseases, especially hepatitis C, are prevalent among drug abusers. Interferon-
alpha (IFN-α) is the pharmacological treatment of choice for this condition. Patients being …

Objective. Neuropsychiatric symptoms are common in patients with chronic hepatitis C
(CHC) and can potentially be exacerbated by interferon-alpha treatment. Such symptoms …